Agilent Technologies and Applied Spectral Imaging Announce Co-Marketing Agreement for Fluorescence In Situ Hybridization
April 07 2016 - 11:00AM
Business Wire
Agilent Technologies Inc. (NYSE:A) and Applied Spectral Imaging
(ASI) today announced they have entered into an agreement to
jointly market ASI’s most advanced GenASIs imaging platforms and
Agilent’s fluorescence in situ hybridization (FISH) products and
solutions, including its Dako Omnis instrument for automated FISH
sample processing.
This agreement is expected to bring to pathology labs the
components for a fully automated, end-to-end FISH workflow.
“We are excited to work with ASI,” said Herman Verrelst, vice
president and general manager of Agilent’s Genomics Solutions
Division and Clinical Applications Division. “Difficulty of
fluorescence-based molecular analysis has always been a major pain
point for our customers. We anticipate that Agilent’s broad
portfolio of FISH reagents and instruments, and ASI’s
industry-leading computer-aided imaging solutions, will address
such critical customer needs and enable laboratories to have a
standardized, efficient and high-quality FISH workflow.”
“ASI is proud to partner with Agilent, a global leader in
diagnostics that shares our main objective to make patient care
better,” said Limor Shiposh, chief executive officer of ASI. “This
agreement will position both companies to support customers in all
stages of workflows.”
About ASI
ASI is a global leader in the development of imaging solutions,
supporting fluorescent, brightfield and spectral image-acquisition,
for karyotyping, FISH and various pathology tests.
The GenASIs automated imaging platforms for pathology and
genetic analysis provide advanced diagnostic aids for pathologists
and cytogeneticists, with reproducible and reliable results.
GenASIs platforms can be used with any brand of brightfield or
fluorescence microscope, and support manual and automatic scanning
for a wide range of workflows and applications, to best suit the
needs, size and budget of any lab.
ASI serves clinical laboratories, life science companies and
research institutions in over 50 countries. Information about ASI
is available at www.spectral-imaging.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in
life sciences, diagnostics and applied chemical markets, is the
premier laboratory partner for a better world. Agilent works with
customers in more than 100 countries, providing instruments,
software, services and consumables for the entire laboratory
workflow. The company generated revenue of $4.04 billion in fiscal
2015 and employs about 12,000 people worldwide. Information about
Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available at www.agilent.com/go/news.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160407005125/en/
EDITORIAL CONTACTS:AgilentVictoria Wadsworth-Hansen, +1
408-553-2005victoria.wadsworth-hansen@agilent.comorApplied Spectral
Imaging+1 800-611-3466sales@spectral-imaging.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024